India’s SPARC Scouts For Allies As Pipeline Drugs Advance, Higher Expenses Lurk
This article was originally published in PharmAsia News
Executive Summary
Sun Pharma Advanced Research Company (SPARC) briefed analysts about its pipeline of drugs under development. While candidates seem to have showed positive results, SPARC will eye partnering prospects to enrich and grow its pipeline.